Provided by Tiger Fintech (Singapore) Pte. Ltd.

Candel Therapeutics, Inc.

8.75
+0.810010.20%
Post-market: 8.750.00000.00%19:59 EDT
Volume:1.02M
Turnover:8.70M
Market Cap:413.31M
PE:-5.03
High:8.79
Open:7.96
Low:7.96
Close:7.94
Loading ...

Candel Therapeutics Inc - Can-2409 Shows Statistically Significant Improvement in Disease-Free Survival

THOMSON REUTERS
·
11 Dec 2024

Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival

GlobeNewswire
·
11 Dec 2024

Promising Potential of Candel Therapeutics’ CAN-2409 Drives Buy Rating

TIPRANKS
·
18 Nov 2024

Candel Therapeutics reports Q3 EPS (33c) vs. (29c) last year

TIPRANKS
·
14 Nov 2024

Candel Therapeutics sees cash runway to end of 1Q25

TIPRANKS
·
14 Nov 2024

BRIEF-Candel Therapeutics Q3 Net Income USD -10.646 Million

Reuters
·
14 Nov 2024

Candel Therapeutics: on Track for Phase 2B & Phase 3 Topline Data in Non-Metastatic, Localized Prostate Cancer for Can-2409 in Q4

THOMSON REUTERS
·
14 Nov 2024

Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

THOMSON REUTERS
·
14 Nov 2024

Candel Therapeutics Q3 Basic EPS USD -0.33

THOMSON REUTERS
·
14 Nov 2024

Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
14 Nov 2024

Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024

GlobeNewswire
·
07 Nov 2024

Candel Therapeutics to present data at SITC annual meeting on CAN-3110

TIPRANKS
·
05 Nov 2024

Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma

GlobeNewswire
·
05 Nov 2024

Candel Therapeutics Advances in Cancer Treatment Trials

TipRanks
·
29 Oct 2024

Candel Therapeutics showcases cancer therapy candidates at IOVC

TIPRANKS
·
28 Oct 2024

Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC)

GlobeNewswire
·
28 Oct 2024